Author

Nagendra sasthri Yarla

Emory University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Aswathy KiD· 1 shared Govinda Rao DuddukuriiD· 1 shared Hima PKiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aswathy KORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 27, 2026

Anti-diabetic drug Repaglinide induces Apoptosis, Cell Cycle Arrest, and Inhibits Cell Migration in Human Breast and Lung Cancer Cells.

Hima PK, Aswathy K, Nagendra sasthri Yarla, Govinda Rao Duddukuri

This study investigates repaglinide's anticancer effects on breast and lung cancer cells, showing cytotoxicity, apoptosis, cell cycle arrest, and reduced migration.

DOI 10.64898/2026.02.25.707939

humanbulk RNA-seq

𝕏 PostBluesky